“…We previously demonstrated pterostilbene as a PPARα agonist, and decreased plasma glucose, very‐low‐density lipoprotein (VLDL)‐, low‐density lipoprotein (LDL)‐, and total cholesterol, and increases HDL‐cholesterol levels in hamsters fed a high‐fat diet, effects that are consistent with PPARα activation . Other groups have also reported anti‐diabetic and hypolipidemic properties of pterostilbene . Resveratrol has been reported to bind to PPARα .…”